胆固醇胆病的风险评分在患有血溶性疾病的患者中表现不佳:PEDI数据库报告
Jennifer Thompson1, Wenly Ruan1, Douglas S Fishman1
1Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States.
Frontiers in pediatrics
|April 23, 2025
概括
目前为选择儿科患者进行内镜逆行胆管瘤学 (ERCP) 治疗常见胆道结石的标准,对于那些患有血溶性疾病的患者来说是不准确的. 这些标准高估了风险,表明需要改进诊断方法.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 肝胆道疾病 肝胆道疾病
- 内镜手术 进行内镜手术
背景情况:
- 患有血溶性疾病的患者面临更高的胆结石并发症风险.
- 现有的评分系统旨在确定儿童患者,他们可能会从ERCP中受益于胆固醇胆病.
研究的目的:
- 评估当前标准在识别患有血溶性疾病的儿科患者的有效性,这些患者可以从ERCP中受益.
- 评估该特定患者群体的确定的选择标准的表现.
主要方法:
- 从儿科ERCP数据库倡议 (1124个ERCP) 收集的前性数据的二次分析.
- 对有血溶性疾病和没有血溶性疾病的患者进行ERCP结果和遵守选择标准的比较.
- 统计分析使用双尾的费舍尔精确测试和配对的学生t测试.
主要成果:
- 在47名患有血溶性疾病的儿科患者中,72.3%在ERCP时患有常见胆道结石 (CBD).
- 在患有CBD石头和没有CBD石头的患者之间,在ERCP前的研究结果中没有显著差异.
- 现有的标准 (ASGE高风险,修改的贝勒) 在这个队列中预测胆固醇结石症的不好,80-90%的没有结石的患者符合高风险标准.
- 在患有血溶性疾病的患者中观察到增加不良事件的趋势.
结论:
- 目前的ERCP选择标准对于患有血溶性疾病的儿科患者来说不足,导致过度估计胆固醇胆病风险.
- 像内镜超声波和MRCP这样的先进成像模式的不足利用可能需要在这个人群中增加它们的使用.
- 需要修订或替代策略,以便在儿科血溶性疾病病例中准确选择ERCP的患者.
相关概念视频
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
386
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
386
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
274
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
274
01:24Chronic Kidney Disease II: Clinical Manifestations
1.1K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
01:20Cholecystitis
32
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
32